| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.94B | 3.10B | 2.33B | 2.30B | 1.48B | 1.08B |
| Gross Profit | 22.36M | 71.64M | 148.80M | 285.51M | 142.80M | 91.41M |
| EBITDA | 29.36M | 77.03M | 163.47M | 294.84M | 168.50M | 115.65M |
| Net Income | -66.50M | -16.04M | 54.92M | 138.23M | 72.47M | 29.09M |
Balance Sheet | ||||||
| Total Assets | 1.61B | 1.68B | 1.66B | 1.08B | 971.94M | 969.90M |
| Cash, Cash Equivalents and Short-Term Investments | 375.55M | 352.62M | 300.71M | 92.47M | 50.08M | 54.44M |
| Total Debt | 369.73M | 338.27M | 262.97M | 165.30M | 51.17M | 82.30M |
| Total Liabilities | 545.87M | 584.85M | 535.95M | 355.88M | 418.55M | 466.66M |
| Stockholders Equity | 965.11M | 985.37M | 1.02B | 573.79M | 457.93M | 400.56M |
Cash Flow | ||||||
| Free Cash Flow | -19.90M | 13.82M | -43.95M | 199.74M | 44.27M | -21.69M |
| Operating Cash Flow | 35.60M | 96.86M | 104.46M | 318.82M | 94.88M | 50.62M |
| Investing Cash Flow | -222.25M | -268.86M | -71.06M | -150.12M | -58.70M | -77.35M |
| Financing Cash Flow | -43.37M | 2.49M | 204.95M | -139.06M | -44.28M | 12.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $1.07B | 8.30 | 3.36% | 7.85% | -5.37% | 25.20% | |
68 Neutral | HK$225.60M | 12.37 | 7.30% | 2.00% | 29.04% | -1.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | HK$616.30M | -17.73 | -14.53% | ― | 0.35% | -153.95% | |
54 Neutral | HK$710.76M | ― | -6.64% | ― | 2.76% | -293.57% | |
54 Neutral | HK$684.44M | -23.59 | -1.52% | 5.35% | 0.37% | -331.54% | |
48 Neutral | HK$86.16M | -0.06 | ― | ― | -15.10% | 31.07% |
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has announced the renewal of its continuing connected transactions through New Framework Agreements with Jinma Energy and Yugang Coking. These agreements, effective from January 2026 to December 2028, involve both exempt and non-exempt transactions under Hong Kong’s Listing Rules, necessitating various reporting and approval processes. The renewal aims to ensure the continuation of business operations with these connected entities, impacting the company’s financial and operational strategies.